Acta Medica Okayama Volume 59, Issue 1 2005 Article 2 F EBRUARY 2005 Selective COX-2 inhibition with different doses of rofecoxib does not impair endothelial function in patients with coronary artery disease. Canan Tikiz * Ozan Utuk † Ozgur Bayturan ‡ Petek Bayindir ** Cenk Ekmekci †† Hakan Tikiz ‡‡ * University of Celal Bayar, † University of Celal Bayar, ‡ University of Celal Bayar, ** University of Celal Bayar, †† University of Celal Bayar, ‡‡ University of Celal Bayar, Copyright c 1999 OKAYAMA UNIVERSITY MEDICAL SCHOOL. All rights reserved.